(Q50152043)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20215482%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Acute cholecystitis in a patient with metastatic renal cell carcinoma treated with everolimus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20215482%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

0 references

1 reference

metastatic renal cell carcinoma

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20215482%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Bulent Cetin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20215482%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Ugur Coskun

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20215482%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Ramazan Yildiz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20215482%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Suleyman Buyukberber

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20215482%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Meltem Baykara

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20215482%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

9 March 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20215482%20AND%20SRC:MED&resulttype=core&format=json

Journal of Oncology Pharmacy Practice

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20215482%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20215482%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20215482%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

274-278

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20215482%20AND%20SRC:MED&resulttype=core&format=json

TOR, a central controller of cell growth

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1078155210363317

mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210363317

Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210363317

Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210363317

mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210363317

Upstream and downstream of mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210363317

Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210363317

Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210363317

Phase I pharmacokinetic and pharmacodynamic study of the oral mammalian target of rapamycin inhibitor everolimus in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210363317

Upstream of the mammalian target of rapamycin: do all roads pass through mTOR?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210363317

mTOR, translation initiation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210363317

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210363317

Temsirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210363317

A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210363317

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210363317

Molecular pathophysiology and physical chemistry of cholesterol gallstones

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210363317

Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210363317

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210363317

Toxicities associated with the administration of sorafenib, sunitinib, and temsirolimus and their management in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210363317

Cholestasis and regulation of genes related to drug metabolism and biliary transport in rat liver following treatment with cyclosporine A and sirolimus (Rapamycin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210363317

21 January 2018

Identifiers

DOI

10.1177/1078155210363317

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20215482%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference